How Geopolitical Rifts Cut Scientific Collaboration
A new study finally puts a number on the extent to which spats hurt research ties. But the bigger story may be the resilience of global science.
Send us a link
A new study finally puts a number on the extent to which spats hurt research ties. But the bigger story may be the resilience of global science.
This study, which analysed how scientific publications are used in patents, finds that open-access research is cited in patents more often than expected, suggesting that open science can strengthen knowledge transfer from academia to innovation and industry.
European universities are behind more than 10% of all patent applications filed at the EPO from within Europe. However, wide variations in patterns of ownership and commercialisation are much in evidence.
Patents remain an important way for research-intensive universities to exploit their work, but the commercialisation scene is changing.
A patent waiver will not help guarantee COVID-19 vaccines equity around the world and instead richer countries should back compulsory licensing, says a new report by the European Federation of Academies of Sciences and Humanities (ALLEA).
Researchers and intellectual-property specialists offer their tips for deciding which discoveries are worth patenting, and how to do the homework needed for success.
Inventor teams with women represent 16% of filed patents, yet are more likely than male teams to create women's health products.
A preliminary network analysis highlights the complex intellectual property landscape behind mRNA-based COVID-19 vaccines.
With a poor return of value, and a huge overhead for research, patents are a bad investment for the academy, this article argues.